Important information about ZOLINZA
ZOLINZA is a medicine used to treat a type of cancer called cutaneous T-cell lymphoma, also called CTCL. ZOLINZA is used in patients when the CTCL gets worse, does not go away, or comes back after treatment with other medicines.
- Before taking ZOLINZA, tell your doctor if you have had a blood clot in your lung or in a vein anywhere in your body, if you have heart problems, if you have high blood sugar or diabetes, or if you have nausea, vomiting, or diarrhea.
- Tell your doctor about all the prescription medicines you are taking, especially valproic acid (to treat seizures) or a blood thinner such as Coumadin (warfarin), as well as nonprescription medicines, vitamins, and herbal supplements.
- If you are pregnant or plan to become pregnant, you should tell your doctor because ZOLINZA may harm your unborn baby. You should discuss with your doctor whether to breast-feed your baby while taking ZOLINZA.
- While taking ZOLINZA, tell your doctor if you have sudden sharp chest pain, shortness of breath, cough with blood, sweating, rapid pulse, anxiety, or fainting because these may be signs of a serious side effect.
- Please read the Patient Information for ZOLINZA and discuss it with your doctor. The physician Prescribing Information also is included on this site.
- You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
ZOLINZA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
This site is intended for residents of the United States, its territories, and Puerto Rico.
20850619(7)-01/10-ZOL